Supplementary Table S6 from Blood-Based Diagnosis and Risk Stratification of Patients with Pancreatic Intraductal Papillary Mucinous Neoplasm (IPMN)

Supplementary Table S6 from Blood-Based Diagnosis and Risk Stratification of Patients with Pancreatic Intraductal Papillary Mucinous Neoplasm (IPMN)

<p>Normalized miRNA profiling data.</p>

Tallennettuna:

Bibliografiset tiedot
Päätekijä:	Chaoyang Zhang (15051876) (author)
Muut tekijät:	Fawaz N. Al-Shaheri (15051879) (author), Mohamed Saiel Saeed Alhamdani (15051882) (author), Andrea S. Bauer (15051885) (author), Jörg D. Hoheisel (15051888) (author), Miriam Schenk (15051891) (author), Ulf Hinz (15051894) (author), Philipp Goedecke (15051897) (author), Karam Al-Halabi (15051900) (author), Markus W. Büchler (15051903) (author), Nathalia A. Giese (15051906) (author), Thilo Hackert (14943832) (author), Susanne Roth (15051909) (author)
Julkaistu:	2025
Aiheet:	Cancer Cancer Detection and Diagnosis Methods and Technology Cancer Prevention Biomarkers Non-coding RNA biomarkers Protein biomarkers Serum biomarkers Cancer risk assessment Computational Methods Artificial intelligence & machine learning Gastrointestinal Cancers Pancreatic cancer Liquid Biopsy
Tagit:	Lisää tagi Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia

Supplementary Table S4 from Blood-Based Diagnosis and Risk Stratification of Patients with Pancreatic Intraductal Papillary Mucinous Neoplasm (IPMN)
Tekijä: Chaoyang Zhang (15051876)
Julkaistu: (2025)

Supplementary Table S1 from Validation of the Clinical Use of GIScar, an Academic-developed Genomic Instability Score Predicting Sensitivity to Maintenance Olaparib for Ovarian Cancer
Tekijä: Raphaël Leman (17314506)
Julkaistu: (2025)

Supplementary Table S2 from Validation of the Clinical Use of GIScar, an Academic-developed Genomic Instability Score Predicting Sensitivity to Maintenance Olaparib for Ovarian Cancer
Tekijä: Raphaël Leman (17314506)
Julkaistu: (2025)

Supplementary Table S3 from Validation of the Clinical Use of GIScar, an Academic-developed Genomic Instability Score Predicting Sensitivity to Maintenance Olaparib for Ovarian Cancer
Tekijä: Raphaël Leman (17314506)
Julkaistu: (2025)

Supplementary Table S4 from Validation of the Clinical Use of GIScar, an Academic-developed Genomic Instability Score Predicting Sensitivity to Maintenance Olaparib for Ovarian Cancer
Tekijä: Raphaël Leman (17314506)
Julkaistu: (2025)

Supplementary Table S5 from Validation of the Clinical Use of GIScar, an Academic-developed Genomic Instability Score Predicting Sensitivity to Maintenance Olaparib for Ovarian Cancer
Tekijä: Raphaël Leman (17314506)
Julkaistu: (2025)

Supplementary Table S6 from Validation of the Clinical Use of GIScar, an Academic-developed Genomic Instability Score Predicting Sensitivity to Maintenance Olaparib for Ovarian Cancer
Tekijä: Raphaël Leman (17314506)
Julkaistu: (2025)

Supplementary Figure S1 from Elucidating the Genetic Landscape of Oral Leukoplakia to Predict Malignant Transformation
Tekijä: Leon J. Wils (15055780)
Julkaistu: (2025)

Supplementary Figure S10 from Elucidating the Genetic Landscape of Oral Leukoplakia to Predict Malignant Transformation
Tekijä: Leon J. Wils (15055780)
Julkaistu: (2025)

Supplementary Figure S11 from Elucidating the Genetic Landscape of Oral Leukoplakia to Predict Malignant Transformation
Tekijä: Leon J. Wils (15055780)
Julkaistu: (2025)

Supplementary Figure S12 from Elucidating the Genetic Landscape of Oral Leukoplakia to Predict Malignant Transformation
Tekijä: Leon J. Wils (15055780)
Julkaistu: (2025)

Supplementary Figure S2 from Elucidating the Genetic Landscape of Oral Leukoplakia to Predict Malignant Transformation
Tekijä: Leon J. Wils (15055780)
Julkaistu: (2025)

Supplementary Figure S4 from Elucidating the Genetic Landscape of Oral Leukoplakia to Predict Malignant Transformation
Tekijä: Leon J. Wils (15055780)
Julkaistu: (2025)

Supplementary Figure S5 from Elucidating the Genetic Landscape of Oral Leukoplakia to Predict Malignant Transformation
Tekijä: Leon J. Wils (15055780)
Julkaistu: (2025)

Supplementary Figure S6 from Elucidating the Genetic Landscape of Oral Leukoplakia to Predict Malignant Transformation
Tekijä: Leon J. Wils (15055780)
Julkaistu: (2025)

Supplementary Figure S7 from Elucidating the Genetic Landscape of Oral Leukoplakia to Predict Malignant Transformation
Tekijä: Leon J. Wils (15055780)
Julkaistu: (2025)

Supplementary Figure S8 from Elucidating the Genetic Landscape of Oral Leukoplakia to Predict Malignant Transformation
Tekijä: Leon J. Wils (15055780)
Julkaistu: (2025)

Supplementary Figure S9 from Elucidating the Genetic Landscape of Oral Leukoplakia to Predict Malignant Transformation
Tekijä: Leon J. Wils (15055780)
Julkaistu: (2025)

Supplementary Table S1 from CD73-Dependent Adenosine Signaling through Adora2b Drives Immunosuppression in Ductal Pancreatic Cancer
Tekijä: Erika Y. Faraoni (14844897)
Julkaistu: (2025)

Supplementary Table S3 from CD73-Dependent Adenosine Signaling through Adora2b Drives Immunosuppression in Ductal Pancreatic Cancer
Tekijä: Erika Y. Faraoni (14844897)
Julkaistu: (2025)

Supplementary Table S4 from CD73-Dependent Adenosine Signaling through Adora2b Drives Immunosuppression in Ductal Pancreatic Cancer
Tekijä: Erika Y. Faraoni (14844897)
Julkaistu: (2025)

Supplementary Table S1 from Exercise Training Reduces the Inflammatory Response and Promotes Intestinal Mucosa-Associated Immunity in Lynch Syndrome
Tekijä: Nan Deng (17314330)
Julkaistu: (2025)

Supplementary Table S2 from Exercise Training Reduces the Inflammatory Response and Promotes Intestinal Mucosa-Associated Immunity in Lynch Syndrome
Tekijä: Nan Deng (17314330)
Julkaistu: (2025)

Supplementary Table S3 from Exercise Training Reduces the Inflammatory Response and Promotes Intestinal Mucosa-Associated Immunity in Lynch Syndrome
Tekijä: Nan Deng (17314330)
Julkaistu: (2025)

Supplementary Table S4 from Exercise Training Reduces the Inflammatory Response and Promotes Intestinal Mucosa-Associated Immunity in Lynch Syndrome
Tekijä: Nan Deng (17314330)
Julkaistu: (2025)

Supplementary Table S5 from Exercise Training Reduces the Inflammatory Response and Promotes Intestinal Mucosa-Associated Immunity in Lynch Syndrome
Tekijä: Nan Deng (17314330)
Julkaistu: (2025)

Supplementary Table S6 from Exercise Training Reduces the Inflammatory Response and Promotes Intestinal Mucosa-Associated Immunity in Lynch Syndrome
Tekijä: Nan Deng (17314330)
Julkaistu: (2025)

Supplementary Table S7 from Exercise Training Reduces the Inflammatory Response and Promotes Intestinal Mucosa-Associated Immunity in Lynch Syndrome
Tekijä: Nan Deng (17314330)
Julkaistu: (2025)

Supplementary Table S8 from Exercise Training Reduces the Inflammatory Response and Promotes Intestinal Mucosa-Associated Immunity in Lynch Syndrome
Tekijä: Nan Deng (17314330)
Julkaistu: (2025)

Supplemental Table 1 from Comprehensive ctDNA Measurements Improve Prediction of Clinical Outcomes and Enable Dynamic Tracking of Disease Progression in Advanced Pancreatic Cancer
Tekijä: Morten Lapin (15056728)
Julkaistu: (2025)

Supplemental Table 2 from Comprehensive ctDNA Measurements Improve Prediction of Clinical Outcomes and Enable Dynamic Tracking of Disease Progression in Advanced Pancreatic Cancer
Tekijä: Morten Lapin (15056728)
Julkaistu: (2025)

Supplemental Table 3 from Comprehensive ctDNA Measurements Improve Prediction of Clinical Outcomes and Enable Dynamic Tracking of Disease Progression in Advanced Pancreatic Cancer
Tekijä: Morten Lapin (15056728)
Julkaistu: (2025)

Supplementary Table 1 from Comprehensive DNA Methylation Analysis Indicates That Pancreatic Intraepithelial Neoplasia Lesions Are Acinar-Derived and Epigenetically Primed for Carcinogenesis
Tekijä: Emily K.W. Lo (15618846)
Julkaistu: (2025)

Supplementary Table 2 from Comprehensive DNA Methylation Analysis Indicates That Pancreatic Intraepithelial Neoplasia Lesions Are Acinar-Derived and Epigenetically Primed for Carcinogenesis
Tekijä: Emily K.W. Lo (15618846)
Julkaistu: (2025)

Supplementary Table 3 from Comprehensive DNA Methylation Analysis Indicates That Pancreatic Intraepithelial Neoplasia Lesions Are Acinar-Derived and Epigenetically Primed for Carcinogenesis
Tekijä: Emily K.W. Lo (15618846)
Julkaistu: (2025)

Supplementary Table 4 from Comprehensive DNA Methylation Analysis Indicates That Pancreatic Intraepithelial Neoplasia Lesions Are Acinar-Derived and Epigenetically Primed for Carcinogenesis
Tekijä: Emily K.W. Lo (15618846)
Julkaistu: (2025)

Supplementary Table 5 from Comprehensive DNA Methylation Analysis Indicates That Pancreatic Intraepithelial Neoplasia Lesions Are Acinar-Derived and Epigenetically Primed for Carcinogenesis
Tekijä: Emily K.W. Lo (15618846)
Julkaistu: (2025)

Supplementary Table 6 from Comprehensive DNA Methylation Analysis Indicates That Pancreatic Intraepithelial Neoplasia Lesions Are Acinar-Derived and Epigenetically Primed for Carcinogenesis
Tekijä: Emily K.W. Lo (15618846)
Julkaistu: (2025)

Supplementary Table 7 from Comprehensive DNA Methylation Analysis Indicates That Pancreatic Intraepithelial Neoplasia Lesions Are Acinar-Derived and Epigenetically Primed for Carcinogenesis
Tekijä: Emily K.W. Lo (15618846)
Julkaistu: (2025)

Figure 1 from Metabolomic Biomarkers in Blood Samples Identify Cancers in a Mixed Population of Patients with Nonspecific Symptoms
Tekijä: James R. Larkin (14936324)
Julkaistu: (2025)

Cannot write session to /tmp/vufind_sessions/sess_5cu71cr02tgo80oap8shs86huu